This provider's $3.6M in total Medicare payments ranks in the 97th percentile of Cardiology providers nationally.
Their average markup ratio of 10.42x is significantly above the specialty median of 3.6x.
Medicare payments to this provider grew 122% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $455.94 | $58.69 | 7.77x | $397.25 | $172.0K | 3.3K | 3.2K |
| 2015 | $451.24 | $64.13 | 7.04x | $387.11 | $252.4K | 4.7K | 4.3K |
| 2016 | $471.66 | $67.75 | 6.96x | $403.91 | $334.0K | 5.4K | 5.1K |
| 2017 | $450.19 | $64.97 | 6.93x | $385.22 | $351.7K | 5.8K | 5.4K |
| 2018 | $556.53 | $69.41 | 8.02x | $487.12 | $407.7K | 6.2K | 5.9K |
| 2019 | $544.60 | $71.74 | 7.59x | $472.86 | $473.6K | 6.8K | 6.4K |
| 2020 | $544.11 | $67.39 | 8.07x | $476.72 | $429.8K | 6.7K | 6.3K |
| 2021 | $589.45 | $69.70 | 8.46x | $519.75 | $411.9K | 6.4K | 6.0K |
| 2022 | $580.92 | $64.62 | 8.99x | $516.30 | $361.9K | 5.6K | 5.3K |
| 2023 | $577.43 | $59.39 | 9.72x | $518.04 | $382.5K | 7.3K | 7.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 12.8K | $1.1M | $88.42 | 15.68x |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | 1.9K | $508.0K | $264.47 | 8.35x |
| 74174 | CT scan of abdominal and pelvic blood vessels with contrast | 1.7K | $355.2K | $209.83 | 8.80x |
| 71275 | CT scan of blood vessels in chest with contrast | 1.6K | $188.5K | $119.37 | 15.13x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 2.1K | $161.9K | $78.83 | 2.73x |
| 75561 | MRI of heart before and after contrast | 970 | $95.3K | $98.24 | 6.07x |
| 71250 | CT scan chest | 1.4K | $93.0K | $68.75 | 15.04x |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.3K | $92.5K | $68.97 | 1.81x |
| 71260 | CT scan chest with contrast | 762 | $71.1K | $93.31 | 12.41x |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 1.4K | $70.1K | $48.75 | 10.52x |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 381 | $67.8K | $177.83 | 1.47x |
| 93000 | Routine EKG using at least 12 leads including interpretation and report | 6.0K | $67.2K | $11.21 | 8.56x |
| 74177 | CT scan of abdomen and pelvis with contrast | 305 | $51.9K | $170.28 | 6.13x |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | 887 | $49.2K | $55.47 | 2.63x |
| 71046 | X-ray of chest, 2 views | 3.0K | $47.7K | $15.75 | 5.46x |
| 75574 | CT scan of heart blood vessels and grafts with contrast dye | 215 | $44.7K | $208.04 | 10.33x |
| J2785 | Injection, regadenoson, 0.1 mg | 956 | $41.6K | $43.47 | 2.59x |
| 71271 | Low dose ct scan of chest for lung cancer screening | 375 | $33.2K | $88.50 | 3.75x |
| 93308 | Follow-up or limited ultrasound examination of heart | 1.2K | $29.8K | $24.08 | 7.70x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 241 | $29.5K | $122.34 | 2.70x |
This provider submits charges 10.42 times higher than what Medicare actually pays.
A markup ratio of 10.42x means for every $100 Medicare pays, this provider initially charges $1042. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data